Phase 2 N=20 Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars
Acne Scars
Primary: Global Scarring Severity — 2.7 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=147 Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction
Atrophic Acne Scar
Primary: ASRS Responder Rate at 6 Months — 32.4; 67.4 percentage of participants
N/A N=10 Tripeptide/Hexapeptide Topical and Hybrid Laser Treatment for Acne Scarring
Acne Scars - Mixed Atrophic and Hypertrophic
Primary: Mean Change From Baseline in Erythema — -1.687; 5.730 units on a scale
N/A N=42 The Use of Bellafill for Atrophic Acne Scar Correction in the Full Facial Area
Atrophic Acne Scarring
Primary: Change on the Acne Scar Assessment Scale (ASAS) — 3.33; 2.19; 2.20 units on a scale
Phase 4 N=67 Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars
Acne Vulgaris · Atrophic Acne Scars
Primary: Part 1: Total Atrophic Acne Scar Count Per Half-face — 9.5; 13.3 atrophic acne scars — p=<0.0001
Phase 2 N=15 Fractional Resurfacing Device for Treatment of Acne Scarring
Acne · Scar
Primary: Overall Improvement of Acne Scarring — 2.26; 1.91 units on a scale
N/A N=14 Clinical Evaluation of Fractional Radiofrequency for the Treatment Acne Scarring
Acne Scars
Primary: Acne Scar Improvement — 0.26 units on a scale
N/A N=25 Clinical Evaluation of Fractional Radiofrequency for the Treatment of Acne Scarring
Acne Scars
Primary: Overall Acne Scar Improvement Assessed by the Global Aesthetic Improvement Scale (GAIS) at 12 Weeks. — 1.06; 0.85 score on a scale
Phase 4 N=49 Performance and Safety of Restylane Lidocaine for Treatment of Depressed Facial Acne Scars
Healthy Volunteers
Primary: Percentage of Participants With Lower Scar Severity in the Treated Cheek Compared to the Untreated Cheek — 81 percentage of participants
Phase 4 N=242 Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation
Acne Vulgaris
Primary: Absolute Change From Baseline in Total Atrophic Acne Scar Count Per Half Face at Week 24 — -5.9; -2.7 atrophic acne scars — p=< 0.0001
N/A N=10 Pilot Study Investigating the Efficacy of Fat Grafting as a Treatment for Male and Female Facial Acne Scarring
Acne Scars - Mixed Atrophic and Hypertrophic · Acne
Primary: Subject Acne Severity Scale — 0; 1; 2; 7 Participants
N/A N=4 Comparison of 1,550-nm Laser and Fractional Radiofrequency Microneedle for the Treatment of Acne Scars in Ethnic Skin
Acne Scars
Primary: Improvement in Acne Scarring - From Baseline to Three Months After Last Treatment — 2; 2 score on a scale
N/A N=30 Post Excision/Mohs Scar Laser Resurfacing
Skin Cancer
Primary: MMSS for Scar Halves Treated — 8.4; 8.7 score on a scale
N/A N=44 A Pilot Study to Evaluate the Safety and Effectiveness of Microneedling and Bellafill to Treat Facial Acne Scars
Atrophic Acne Scars
Primary: Acne Scar Assessment Scale (ASAS) — 2.65; 3.71 units on a scale
N/A N=10 Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles
Acne Scars - Mixed Atrophic and Hypertrophic · Wrinkle
Primary: Overall Wrinkle Improvement Assessed by the Fitzpatrick Wrinkle and Elastosis Scale (FWES) at 12 Weeks Post-Final Treatment — 5.97; 5.78 units on a scale
Phase 3 N=122 Safety and Efficacy Study of Autologous Fibroblasts in the Treatment of Severe Facial Acne Scarring
Acne Scarring of the Face
Primary: Evaluator Live Acne Scarring Assessment Responders — 64; 46 Participants — p=0.0109
N/A N=20 Clinical Evaluation of the Safety and Performance of FRF for the Treatment and Reduction of Acne Scarring
Acne Scars - Mixed Atrophic and Hypertrophic
Primary: Subject Satisfaction — 3.5 units on a scale
N/A N=20 Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars
Acne Scars
Primary: Severity Change in Acne Scarring — -2 score on a scale
Phase 4 N=12 An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital Lidocaine
Acne Scars
Primary: Evaluation of Acne Scarring and the Surrounding Skin Using the Global Aesthetic Improvement Scale — 100 percentage of participants
N/A N=51 Treatment of Surgical Scars Following Breast Augmentation, Abdominoplasty or Face Lift
Surgical Scar · Breast Augmentation · Abdominoplasty
Primary: Improvement of Surgical Scars at 12 Months Compared to Baseline (Pre-treatment) as Evaluated by 3 Independent Blinded Reviewers Using the General Aesthetic Improvement…
N/A N=21 The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars
Acne Scars
Primary: Percentage of Participants With Facial Acne Improvement Using the Global Aesthetic Improvement Scale — 28.6; 57.1; 14.3 percentage of participants
N/A N=43 enLighten Laser With MLA Handpiece for Treatment of Moderate and Severe Acne Scars
Acne Scars - Mixed Atrophic and Hypertrophic
Primary: Correct Identification of the 12 Weeks Post-final Treatment Photographs From the Baseline Photographs by at Least 2 of the 3 Blinded Reviewers in 75% of the Patients…
N/A N=6 Laser Resurfacing Versus Dermabrasion for Scar Revision
Cicatrix · Dermabrasion · Coagulation, Laser
Primary: Safey Data Score Based on Ordinal Ratings of Erythema, Edema, Bleeding, Eschar After Resurfacing — 1.33; 3.00; 0; 0 units on a scale
N/A N=4 Evaluation of the Cutera Enlighten™ Laser With Micro-Lens Array (MLA) Handpiece Attachment
Scarring · Acne
Primary: Acne Scarring Improvement — 4; 4 score on a scale
Phase 2 N=150 Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne
Acne Vulgaris
Primary: Proportion of Success, Defined as Improvement of at Least 2 Grades From Baseline According to the IGA Scale Based on Facial Assessment — 16; 14.58; 11.54 Percentage of…
N/A N=20 Treatment of Post-Surgical Scars With Traditional Ablative Er:YAG Versus Fractional Ablative Er:YAG
Post-Surgical Scars
Primary: Patient Observer Scar Assessment Scale (POSAS) — 17.69; 11.2; 15.2; 11.4 units on a scale — p=0.019
Phase 2 N=60 Light Emitting Diode-Red Light (LED-RL) Phototherapy for Skin Scarring Prevention
Fibrosis · Skin Scarring · Skin Wound
Primary: Change in Scar Pliability Between the Treated and Control Incision Sites as Measured by Skin Elasticity at 6 Months Compared to Baseline
N/A N=40 Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.
Acne · Scars
Primary: Number of Partecipants With Improvement of Acne Scars and Marks and Without New Acne Scars After 4 Weeks — 5 participants
N/A N=41 SkinPen Efficacy on Acne Scars on the Face and/or Back
Atrophic Acne Scar
Primary: Severity of Acne Scars — 3.19; 3.10; 2.81; 2.90 score on a scale — p=<0.008
Phase 2 N=44 Non-cutting Laser Therapy in the Treatment of Acne
Acne Vulgaris
Primary: Change From Baseline in Papule Acne Lesions at Week 10 — -4.63; -0.13 papule acne lesions — p=0.01